Newzulu signals mobile shift with Octiplex acquisition

Published 18-SEP-2015 11:55 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Media tech player Newzulu (ASX:NWZ) has beefed up its mobile offering by completing a deal worth $1.15 million – and has already bagged its first mobile client.

NWZ told the market this morning that it had completed the acquisition of mobile development company Octiplex – allowing NWZ to bring mobile development in house.

It said the development of in-house mobile development would be crucial in the years ahead, citing data from Cisco Visual indicating the number of mobile devices connected to the Internet would be three times as high as the gobal population by 2019.

Cisco has also estimated that mobile will responsible for 62% of all Internet traffic by 2019, with global mobile data to grow ten-fold in that time.

Mobile video traffic is set to grow 13-fold to 2019, an annual growth rate of 66%.

It’s for this reason NWZ has been looking to develop mobile application and bespoke mobile solutions for clients in house.

The deal to acquire Octiplex is for an upfront cash amount of $574,330, with the rest being taken in NWZ with a 12 month restriction period.

NWZ has already gone some way to repaying the investment, announcing that it had bagged an application development contract worth $225,000 over a four month period.

The Optiplex deal also comes with a new mobile division, with Optiplex founder Damien Gosset jumping on board as the new unit’s senior vice president.

About NWZ

In short, NWZ is a way for news publishers to connect with citizen journalists who are on the scene of unfolding news.

While in the past, citizen journalists had to take the video, contact a newsroom, and then wait for them to make an offer on the footage, the Newzulu system takes a lot of the gruntwork out of the equation.

Citizen journalists simply log onto the Newzulu platform, upload the footage and then wait for the cash to roll in.

NWZ verifies the content to make sure it’s legitimate, and then pays the citizen journalist a fee for the content. Then a Newzulu partner such as Agence France Presse or Getty Images then onsells the footage to news organisations which have paid for access to the Newzulu library.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free